doc. RNDr. Lenka Zdražilová Dubská, Ph.D.
Associate professor, Center of excellence CREATIC
Office: bldg. C03/333
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8238 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 108
2021
-
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI
Journal of Medical Virology, year: 2021, volume: 93, edition: 3, DOI
-
PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, year: 2021, volume: 13, edition: December 2021, DOI
-
Strict Adherence to Anti-Epidemic Measures PreventsICU Staff from SARS-Cov2 Infection
Biomedical and Pharmacology Journal, year: 2021, volume: 14, edition: 4, DOI
-
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients
Hematological Oncology, year: 2021, volume: 39, edition: 5, DOI
2020
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside
Frontiers in Oncology, year: 2020, volume: 9, edition: FEB 2020, DOI
-
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
Year: 2020, type: Article in Periodical (without peer review)
-
Naléhavé nálezy v hematologické laboratorní a klinické diagnostice aneb kdy je nutno zpozornět a zejména upozornit.
Year: 2020
-
Úskalí laboratorních metod v ovariálním skríninku - doba "-omická"?
Onkologie, year: 2020, volume: 14, edition: 2, DOI
2019
-
Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
Frontiers in Oncology, year: 2019, volume: 9, edition: NOV 14 2019, DOI
-
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome
Frontiers in Oncology, year: 2019, volume: 9, edition: OCT 25 2019, DOI